Longevity Peptide Research: Mapping Compounds to the Hallmarks of Ageing

How Epitalon, MOTS-c, GHK-Cu, NAD+ and glutathione map onto the hallmarks of ageing framework, with honest notes on the strength of the evidence.

Share
Longevity Peptide Research: Mapping Compounds to the Hallmarks of Ageing

"Longevity peptides" is one of the fastest-growing search terms in the research compound market, driven by the broader biohacking movement. The phrase covers a loose group of compounds that have been studied in relation to ageing biology. The quality of evidence across that group varies enormously, from substantial preclinical literatures to a handful of studies from a single lab. A useful way to make sense of it is to map each compound onto an established scientific framework and ask what, specifically, the research has measured.

Overview of this guide

The hallmarks of ageing

In 2013, Carlos López-Otín and colleagues published "The hallmarks of aging" in Cell, proposing nine interconnected processes that drive ageing. A 2023 update, "Hallmarks of aging: an expanding universe," expanded the list to twelve:

  1. Genomic instability
  2. Telomere attrition
  3. Epigenetic alterations
  4. Loss of proteostasis
  5. Disabled macroautophagy
  6. Deregulated nutrient sensing
  7. Mitochondrial dysfunction
  8. Cellular senescence
  9. Stem cell exhaustion
  10. Altered intercellular communication
  11. Chronic inflammation
  12. Dysbiosis

The framework is widely used to organize ageing research. It does not rank interventions, and it is careful to note that the hallmarks interact.

Mapping research compounds to the hallmarks

Telomere attrition: Epitalon

Epitalon is a synthetic tetrapeptide. A 2003 cell culture study by Khavinson and colleagues reported telomerase activity and telomere elongation in human fetal fibroblasts. Independent replication is limited, and evidence in whole organisms is mostly from the original group's rodent work. See our Epitalon research article for details.

Mitochondrial dysfunction and nutrient sensing: MOTS-c and NAD+

MOTS-c is a peptide encoded in mitochondrial DNA. Mouse and cell research reported associations with AMPK activation and metabolic measures, and a 2021 study reported that endogenous levels rose with exercise in people. NAD+ is a coenzyme whose levels decline with age in many tissues in rodent studies; reviews of precursor research in animals report changes in mitochondrial and metabolic measures, while human studies remain small. Both compounds connect to mitochondrial function and nutrient sensing. See MOTS-c and NAD+.

Altered intercellular communication and tissue remodelling: GHK-Cu

GHK-Cu is a copper-binding tripeptide found in plasma. Gene-expression analyses in cultured cells reported broad expression changes, including in tissue-remodelling and antioxidant genes. See GHK-Cu.

Oxidative damage and proteostasis: glutathione

Glutathione is the main cellular thiol antioxidant. Its redox ratio is a standard marker of oxidative stress, and research has reported age-associated changes in some tissues. See Glutathione.

Chronic inflammation: KPV

KPV is a tripeptide fragment of α-MSH. Mouse and cell research reported reduced inflammatory signalling in intestinal models. Inflammation is one of the newer hallmarks in the 2023 update. See KPV.

Pineal and neuropeptide research: Pinealon and DSIP

Pinealon, a short peptide from the same research tradition as Epitalon, and DSIP, first isolated in 1977 in sleep research in rabbits, are also studied in neuroscience-adjacent ageing research. Their literatures are small.

Evaluating longevity claims

Online content about longevity peptides often skips several steps between a cell culture result and a claim about human lifespan. A simple set of questions keeps research honest:

  1. What model? Cell line, worm, fly, mouse or human?
  2. What outcome? A biomarker, a gene-expression change, a functional measure or lifespan?
  3. Who did the work? One group, or several independent groups?
  4. Has it been replicated?
  5. Is the human evidence controlled? Observational data, small pilot studies and randomized trials carry very different weight.

By these standards, none of the compounds above has controlled evidence of extending human lifespan or healthspan. They are research tools for studying ageing biology.

Key points for labs

A note on biohacking

The biohacking community has done a lot to popularize ageing science, but it has also blurred the line between research and personal experimentation. Research compounds are not tested or approved for human use, and Morpheus Research sells them for laboratory research only.

Building a longevity research programme

Labs working across several of these compounds benefit from consistent sourcing and documentation: batch certificates for each lot, matched handling procedures and careful records. Browse the full catalogue or contact us for multi-compound wholesale pricing through the contact page.

Biomarkers used in ageing research

Because lifespan studies take years in mammals, most ageing research relies on biomarkers. Understanding them helps readers evaluate claims about any compound.

  • Telomere length, measured in blood cells or tissues. It varies widely between individuals and is a noisy marker on its own.
  • Epigenetic clocks, which estimate biological age from DNA methylation patterns at selected sites. Several clocks exist, and they do not always agree.
  • Senescence markers, such as senescence-associated β-galactosidase staining and p16 expression, used mainly in cells and animal tissues.
  • Mitochondrial function, including respiration measured in isolated cells or tissue samples.
  • NAD+ levels and related metabolites.
  • Inflammatory markers in blood, sometimes grouped under the term "inflammaging."
  • Functional measures in animals, such as grip strength, treadmill endurance and frailty indices.

A change in a biomarker is not the same as a change in ageing. Many interventions shift one marker without affecting others, and some markers can be changed without any functional effect.

Interventions with stronger evidence in models

Context helps. Some interventions have much larger evidence bases in ageing models than any research peptide. Caloric restriction has been studied across yeast, worms, flies and rodents for decades, with lifespan effects reported in many models. The US National Institute on Aging's Interventions Testing Program tests compounds in genetically diverse mice across multiple sites, a design intended to make results more robust. Comparing the evidence for any research compound against that standard of multi-site replication shows how early most longevity peptide research still is.

Designing a multi-compound programme

Labs studying several compounds face an extra challenge: keeping comparisons fair. Useful practices include using the same model, outcome measures and handling procedures for each compound; including a shared vehicle control; and buying each compound from documented lots with certificates on file. Where compounds act on different hallmarks, as with a mitochondrial peptide and a copper peptide, it helps to choose outcome measures that capture several hallmarks rather than only the one each compound is thought to target.

Frequently asked questions

What are longevity peptides? An informal term for research compounds studied in relation to ageing biology.

What are the hallmarks of ageing? A framework of twelve interconnected processes that drive ageing, updated in 2023.

Do longevity peptides extend lifespan in people? No controlled human evidence shows this. Most findings come from cell or animal models.

Which compound has the most research? NAD+ and its precursors have the largest literature among those listed, though human trials remain small.

Is NAD+ a peptide? No, it is a coenzyme, but it is commonly studied alongside peptides.

References

  • López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. Hallmarks of aging: an expanding universe. Cell. 2023;186(2):243-278. PMID: 36599349.
  • Khavinson VK, Bondarev IE, Butyugov AA. Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells. Bull Exp Biol Med. 2003;135(6):590-592. PMID: 12937682.
  • Lee C, et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metab. 2015;21(3):443-454. PMID: 25738459.
  • Pickart L, Margolina A. Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data. Int J Mol Sci. 2018;19(7):1987. PMID: 29986520.

Research use only. All products sold by Morpheus Research are intended strictly for laboratory research and are not for human or veterinary consumption. Nothing in this article is medical advice, and no statement here is intended to diagnose, treat, cure or prevent any condition. Study findings are reported as published and should not be read as evidence of effects in people.

For research use only. Not for human consumption.